These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 37224002)
21. Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and heart failure. Li G; Lu Z; Chen Z Front Immunol; 2024; 15():1424308. PubMed ID: 39351239 [TBL] [Abstract][Full Text] [Related]
22. Bioinformatics analysis of fibroblasts exposed to TGF‑β at the early proliferation phase of wound repair. Mi B; Liu G; Zhou W; Lv H; Zha K; Liu Y; Wu Q; Liu J Mol Med Rep; 2017 Dec; 16(6):8146-8154. PubMed ID: 28983581 [TBL] [Abstract][Full Text] [Related]
23. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma. Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690 [TBL] [Abstract][Full Text] [Related]
24. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer. Yang C; Gong A Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215 [No Abstract] [Full Text] [Related]
25. Identification of Differential Intestinal Mucosa Transcriptomic Biomarkers for Ulcerative Colitis by Bioinformatics Analysis. Cheng F; Li Q; Wang J; Zeng F; Wang K; Zhang Y Dis Markers; 2020; 2020():8876565. PubMed ID: 33144895 [TBL] [Abstract][Full Text] [Related]
26. Identification of Hub Genes in Type 2 Diabetes Mellitus Using Bioinformatics Analysis. Lin Y; Li J; Wu D; Wang F; Fang Z; Shen G Diabetes Metab Syndr Obes; 2020; 13():1793-1801. PubMed ID: 32547141 [TBL] [Abstract][Full Text] [Related]
27. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis. Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263 [TBL] [Abstract][Full Text] [Related]
28. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis. Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961 [TBL] [Abstract][Full Text] [Related]
29. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma. Li J; Liu X; Cui Z; Han G Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582 [TBL] [Abstract][Full Text] [Related]
30. Common gene signatures and key pathways in hypopharyngeal and esophageal squamous cell carcinoma: Evidence from bioinformatic analysis. Zhou R; Liu D; Zhu J; Zhang T Medicine (Baltimore); 2020 Oct; 99(42):e22434. PubMed ID: 33080677 [TBL] [Abstract][Full Text] [Related]
31. Gene Expression Profiling of Type 2 Diabetes Mellitus by Bioinformatics Analysis. Zhu H; Zhu X; Liu Y; Jiang F; Chen M; Cheng L; Cheng X Comput Math Methods Med; 2020; 2020():9602016. PubMed ID: 33149760 [TBL] [Abstract][Full Text] [Related]
32. Comparison of critical biomarkers in 2 erectile dysfunction models based on GEO and NOS-cGMP-PDE5 pathway. Wang G; Shen D; Zhang X; Ferrini MG; Li Y; Liao H Medicine (Baltimore); 2021 Oct; 100(41):e27508. PubMed ID: 34731136 [TBL] [Abstract][Full Text] [Related]
33. Identification of hub genes, pathways, and related transcription factors in systemic lupus erythematosus: A preliminary bioinformatics analysis. Wang Y; Ma Q; Huo Z Medicine (Baltimore); 2021 Jun; 100(25):e26499. PubMed ID: 34160465 [TBL] [Abstract][Full Text] [Related]
34. Integrated bioinformatics analysis for exploring hub genes and related mechanisms affecting the progression of gastric cancer. Wang Y; Li D; Li D; Wang H; Wu Y Biotechnol Genet Eng Rev; 2024 Dec; 40(4):4911-4922. PubMed ID: 37243583 [TBL] [Abstract][Full Text] [Related]
35. Identification of hub genes and key pathways in arsenic-treated rice (Oryza sativa L.) based on 9 topological analysis methods of CytoHubba. Yu Z; Wang R; Dai T; Guo Y; Tian Z; Zhu Y; Chen J; Yu Y Environ Health Prev Med; 2024; 29():41. PubMed ID: 39111872 [TBL] [Abstract][Full Text] [Related]
36. The identification of a common different gene expression signature in patients with colorectal cancer. Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244 [TBL] [Abstract][Full Text] [Related]
37. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis. Chen B; Sun D; Qin X; Gao XH Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609 [TBL] [Abstract][Full Text] [Related]
38. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus. Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912 [TBL] [Abstract][Full Text] [Related]
39. Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice. Zhao J; He K; Du H; Wei G; Wen Y; Wang J; Zhou X; Wang J PeerJ; 2022; 10():e13932. PubMed ID: 36157062 [TBL] [Abstract][Full Text] [Related]
40. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma. Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]